The Future of Regenerative Healthcare
Discover our journey in revolutionizing regenerative medicine to enhance patient outcomes.
What is LUX Therapeutics?
Innovating tissue allografts to unlock regenerative therapies and transform patient care worldwide.
We unlock regenerative therapies to transform healthcare and improve lives. Through collaboration and ethical practices, Lux Therapeutics develops new approaches, advances technology, and trains future leaders in regenerative medicine.

Our Values
Innovation
Fostering advanced research and development in regenerative medicine.
Collaboration
Partnering with industry leaders, scientists, and healthcare professionals.
Ethical Responsibility
Upholding high standards of patient safety, efficacy, and ethical practices.

Our Mission
LUX's mission is to advance the field of regenerative medicine through innovative research and development of novel therapies.
Our Vision
To pioneer a future where regenerative medicine is the standard of care, and all patients have access to the transformative power of these innovative therapies.


Founder & President
Jonathan Goss, MD
Dr. Jonathan L. Goss, a Houston native, is a doctor, scientist, and entrepreneur inspired by Dr. King’s quote, "Life’s most persistent and urgent question is ‘What are you doing for others?’." He graduated from Morehouse College, Emory School of Medicine, and trained at Ohio State University. During the COVID-19 pandemic, he founded Emergent Testing for quick, accurate results and developed the telehealth service EmergentNOW. His innovative healthcare companies aim to meet patient needs and support providers, improving lives daily through personalized and compassionate care.
100+
5-Star Ratings
3 Years
In Business
Our Laboratory
All LUX products are produced at our state-of-the-art laboratory in Atlanta, GA.
As a leading lab in the Southeast, our dedicated team transforms healthcare through innovative and effective medical solutions. From lab testing services to regenerative medicine, the LUX brand empowers healthcare providers with the tools they need to improve patient experiences and outcomes.
Our Process
An Emphasis on Quality From Start to Finish
FDA 21 CFR 1271 & Section 361 (PHS Act) Compliant
Extensive Donor Screening
Donors that have scheduled C-sections and are thoroughly tested for a wide range of risk factors and diseases that ensure a high safety standard.
Tissue recovery
Tissue is recovered by a certified tissue recovery team using techniques approved by the American Association of Tissue Banks (AATB).
Processing
Tissue is processed in our state-of-the-art ISO 5 Lab. Our Clean Room operates under strict compliance with state and federal regulations.
Quality Testing
Upon completion of processing and extensive quality testing, all records pertaining to the tissue are thoroughly reviewed and approved by our medical director.
Ready to Discover the Power of Regenerative Medicine?
Leaders in Regenerative Health Products
13 Corporate Blvd NE
Atlanta, GA 30329
(229) 442-7210
info@luxtherapeutics.com
© 2024 LUX Therapeutics. All Rights Reserved.
Disclaimer: Lux Therapeutics, LLC products are purposed for homologous use ONLY. All products are not intended to be drug products that diagnose, treat, cure, or prevent any disease or condition. Lux Therapeutics, LLC does not offer Mesenchymal Stem Cells or Wharton’s Jelly as a cure for any condition, disease, or injury. No statements or implied treatments on our website or marketing material have been evaluated or approved by the FDA. This material contains no medical advice. All statements and opinions provided by this website are provided for educational and informational purposes only and we do not diagnose or treat via this website, marketing material, or telephone. Lux Therapeutics, LLC does not claim that any applications, or potential applications, using our products are approved by the FDA, or are even effective. We do not claim that these treatments work for any listed or unlisted condition, intended or implied. It’s important for potential patients to do their own research based on the options that we present and consultation with their physician.